Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RANIMUSTINE Cause Product use in unapproved indication? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product use in unapproved indication have been filed in association with RANIMUSTINE. This represents 5.0% of all adverse event reports for RANIMUSTINE.

11
Reports of Product use in unapproved indication with RANIMUSTINE
5.0%
of all RANIMUSTINE reports
3
Deaths
2
Hospitalizations

How Dangerous Is Product use in unapproved indication From RANIMUSTINE?

Of the 11 reports, 3 (27.3%) resulted in death, 2 (18.2%) required hospitalization.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RANIMUSTINE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does RANIMUSTINE Cause?

Febrile neutropenia (25) Drug ineffective (24) Haemolytic anaemia (16) Thrombotic microangiopathy (16) Hepatitis b (14) Hypoxia (14) Ventricular hypokinesia (14) Acute kidney injury (13) Bone marrow failure (12) Cardiac failure (12)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which RANIMUSTINE Alternatives Have Lower Product use in unapproved indication Risk?

RANIMUSTINE vs RANITIDINE RANIMUSTINE vs RANITIDINE\RANITIDINE RANIMUSTINE vs RANOLAZINE RANIMUSTINE vs RAPAMUNE RANIMUSTINE vs RASAGILINE

Related Pages

RANIMUSTINE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication RANIMUSTINE Demographics